文献速递泌尿生殖与妇科肿瘤放疗姑息放疗与转移瘤

前列腺癌幸存者接受治愈性放疗联合长期雄激素剥夺治疗后的晚期不良健康结局与生活质量:与一般人群男性的比较

Late Adverse Health Outcomes and Quality of Life after curative radiotherapy + long-term ADT in Prostate Cancer Survivors: Comparison with men from the general population.
PubMed 文献 · Clin Transl Radiat Oncol · 2022-08-06

研究纳入接受治愈性放疗后平均9年的1231例前列腺癌幸存者和3156例无前列腺癌诊断的年龄相似一般人群男性,完成EPIC-26和EORTC QLQ-C30问卷。仅肠道和性功能领域汇总评分差异超过最小临床重要差异;幸存者中54%存在至少一项中度/重度问题(一般人群为30%)。多变量校正后生活质量相似,一般健康状况是最强协变量;泌尿和肠道问题减轻可提高生活质量。

要点

  • 幸存者中54%存在至少一项中度/重度泌尿、肠道或性问题,一般人群为30%。
  • 仅肠道和性功能领域汇总评分差异超过相应最小临床重要差异。
  • 生活质量随泌尿和肠道问题减少而提高,性功能关联在幸存者中几乎缺失。

核心结论

  • 长期前列腺癌幸存者随访中,医疗人员应关注与生活质量降低相关的持续中度/重度泌尿、肠道或性问题。
  • 特别是减轻泌尿和肠道问题可提高男性生活质量。

研究设计与样本

  • 研究比较1231例接受治愈性放疗后平均9年的前列腺癌幸存者与3156例无前列腺癌诊断的年龄相似一般人群男性。
  • 两组均完成EPIC-26问卷和EORTC QLQ-C30量表,计算泌尿、肠道和性功能领域汇总评分、中度/重度功能障碍百分比及总体问题比例。
  • 采用已发表的最小临床重要差异截断值解读组间差异,并用多变量线性回归分析生活质量与领域相关总体问题的关联。

主要发现

  • 仅肠道和性功能领域汇总评分的组间差异超过相应最小临床重要差异。
  • 幸存者中54%存在至少一项中度/重度问题,一般人群为30%。
  • 在幸存者和一般人群中,生活质量随泌尿和肠道问题减少而提高;性功能关联在一般人群中较弱,在幸存者中几乎缺失。
  • 多变量校正后生活质量在幸存者和一般人群中相似,一般健康状况是最强协变量。

关键数值与推荐

  • 幸存者中至少一项中度/重度问题比例为54%,一般人群为30%。
  • 仅肠道和性功能领域汇总评分差异超过已发表的最小临床重要差异截断值。

临床怎么用

  • 长期前列腺癌幸存者随访中,医疗人员应关注持续中度/重度泌尿、肠道或性问题及其与生活质量降低的关联。
  • 减轻泌尿和肠道问题可提高男性生活质量。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Few studies have described the impact of urinary, bowel and sexual Adverse Health Outcomes (AHOs) on Quality of Life (QoL) in Prostate Cancer Survivors living for more than 5 years after curative radiotherapy ("long-term PCaSs"), and compared the findings with those in men from general population. Here we assess self-reported AHOs in such PCaSs focusing on the association between problem experience and QoL. The findings are compared to corresponding symptoms in age-similar men from the general population without a PCa diagnosis (Norms). METHODS: Nine years (mean) after curative radiotherapy 1231 PCaSs and 3156 Norms completed the EPIC-26 questionnaire and the EORTC QLQ-C30 instrument. Domain Summary Scores (DSSs) for the urinary, bowel and sexual domains, the percentages of moderate/big dysfunctions and the proportions of overall problems were determined. Inter-cohort differences were interpreted based on cut-off values for published Minimal Clinically Important Differences (MCIDs). Multivariable linear regression models analyzed the associations between QoL and domain-related overall problems. RESULTS: Only the inter-cohort differences regarding bowel and sexual DSSs exceeded the respective MCIDs. Among PCaSs 54% had at least one moderate/big problem (Norms: 30%). In PCaSs and Norms, QoL increased with decreasing urinary and bowel problems, For sexuality this association was weaker in Norms and was almost lacking in PCaSs. Multivariable-adjusted QoL was similar in PCaSs and Norms, with general health being the strongest covariate. CONCLUSIONS: During follow-up of long-term PCaSs health professionals should be aware of the survivors' persisting moderate/big urinary, bowel or sexual problems associated with reduced QoL. In particular , alleviation of urinary and bowel problems can increase the men's QoL.

来源:Clin Transl Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Fosså SD, Dahl AA, Johannesen TB, et al. Late Adverse Health Outcomes and Quality of Life after curative radiotherapy + long-term ADT in Prostate Cancer Survivors: Comparison with men from the general population. Clin Transl Radiat Oncol. 2022. PMID: 36093341. doi:10.1016/j.ctro.2022.08.003

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。